Tech Company Financing Transactions

Transport Pharmaceuticals Funding Round

Transport Pharmaceuticals, operating out of Framingham, secured $12.6 million in investment from Quaker Partners, The Carlyle Group and EGS Healthcare Capital Partners.

Transaction Overview

Company Name
Transport Pharmaceuticals
Announced On
7/31/2006
Transaction Type
Venture Equity
Amount
$12,600,000
Round
Series D
Investors

Quaker Partners (Lead Investor) (Richard Kollender)

The Carlyle Group (Lead Investor)

EGS Healthcare Capital Partners

Hillman Company

Proceeds Purpose
The additional funds will support our lead drug/device combination product for herpes labialis, or cold sores. We will initiate a Phase II human clinical trial to evaluate the effectiveness of our new drug delivery device and proprietary acyclovir formulation. It will also help to advance the preclinical development of the Company's onychomycosis and other product candidates.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
161 Worcester Road 402
Framingham, MA 01701
USA
Phone
(508) 872-0433
Website
www.transportpharma.com
Email Address
[email protected]
Overview
Transport is revolutionizing the treatment of dermal diseases by bringing together cutting edge electronics, drug formulation and materials science to develop novel drug/device combination products.
Profile
Transport Pharmaceuticals LinkedIn Company Profile
Social Media
Transport Pharmaceuticals Company Twitter Account
Company News
Transport Pharmaceuticals News
Facebook
Transport Pharmaceuticals on Facebook
YouTube
Transport Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dennis Goldberg
  Dennis Goldberg LinkedIn Profile  Dennis Goldberg Twitter Account  Dennis Goldberg News  Dennis Goldberg on Facebook
Vice President
Eric Morrel
  Eric Morrel LinkedIn Profile  Eric Morrel Twitter Account  Eric Morrel News  Eric Morrel on Facebook
VP - Operations
Robert Etheredge
  Robert Etheredge LinkedIn Profile  Robert Etheredge Twitter Account  Robert Etheredge News  Robert Etheredge on Facebook
VP - R & D
Phillip Friden
  Phillip Friden LinkedIn Profile  Phillip Friden Twitter Account  Phillip Friden News  Phillip Friden on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/31/2006: WiNetworks venture capital transaction
Next: 7/31/2006: CoVi Technologies venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.